2-isobutylmercapto-1H-imidazole | 98337-31-6

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 2-isobutylmercapto-1H-imidazole
• 英文别名: 2-Isobutylmercapto-1H-imidazol；2-(2-methylpropylsulfanyl)-1H-imidazole
• CAS: 98337-31-6
• 化学式: C₇H₁₂N₂S
• 分子量: 156.252
• InChiKey: FNSBHJDBTXYRDY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  54
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Viral Polymerase Inhibitors
  申请人：Beaulieu L. Pierre

  公开号：US20080045516A1

  公开（公告）日：2008-02-21

  Compounds of formula I: wherein X, R 2 , R 3 , R 5 and R 6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.

  式I的化合物： 其中X，R2，R3，R5和R6如本文所定义，可用作乙型肝炎病毒NS5B聚合酶的抑制剂。
• N-heteroaryl indole carboxamides and analogues thereof, for use as glcokinase activators in the treatment of diabetes
  申请人：Lau F. Jesper

  公开号：US20070027140A1

  公开（公告）日：2007-02-01

  This invention relates to compounds that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial. The compounds are of the general formula (I) wherin A and B are further defined in the application.

  本发明涉及激活葡萄糖激酶的化合物，因此可能对增加葡萄糖激酶活性有益的疾病的管理、治疗、控制或辅助治疗具有用处。这些化合物的一般式为（I）其中A和B在申请中有进一步定义。
• N-HETEROARYL INDOLE CARBOXAMIDES AND ANALOGUES THEREOF, FOR USE AS GLUCOKINASE ACTIVATORS IN THE TREATMENT OF DIABETES
  申请人：Lau Jesper F.

  公开号：US20110082144A1

  公开（公告）日：2011-04-07

  This invention relates to compounds that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial. The compounds are of the general formula (I) wherein A and B are further defined in the application.

  本发明涉及一种激活葡萄糖激酶的化合物，因此可能有助于管理、治疗、控制或辅助治疗增加葡萄糖激酶活性有益的疾病。该化合物的一般公式为(I)，其中A和B在申请中有进一步定义。
• ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS
  申请人：TECHNISCHE UNIVERSITÄT BERLIN

  公开号：US20150376120A1

  公开（公告）日：2015-12-31

  Antibiotically active compounds characterized by general formula (I), wherein X1, BB, BC, BD, BE and X2 are building blocks with D1, D2, D3, D4 or D5 being linkers which include carbon, sulphur, nitrogen, phosphor and/or oxygen atoms and which are covalently connecting the moities BA and BB, BB and BC, BC and BD, BD and BE and BE and BF, respectively, and wherein in particular the building block BC comprises an amino acid derivative. The compounds for use in a method of treatment of diseases, in particular for use in a method of treatment of bacterial infections are also disclosed.

  具有一般式（I）的抗生素活性化合物的特征，其中X1、BB、BC、BD、BE和X2是具有D1、D2、D3、D4或D5连接器的构建块，包括碳、硫、氮、磷和/或氧原子，并且共价连接BA和BB、BB和BC、BC和BD、BD和BE以及BE和BF的基团，其中特别是构建块BC包括一种氨基酸衍生物。该化合物用于治疗疾病的方法，特别是用于治疗细菌感染的方法。
• Fluorenone derivatives, process for preparing the same and central or peripheral nerve degeneration repair and protective agent
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP0791570A1

  公开（公告）日：1997-08-27

  The present invention provides novel fluorenone derivatives represented by formula (A) (wherein Ra-Rg are defined in the specification), and a method for repairing and protecting central or peripheral nerve degeneration comprising use of a fluorenone derivative represented by formula (1) (wherein R1, R2, p and q are as defined in the specification) as an active component.

  本发明提供了式(A)代表的新型芴酮衍生物（其中Ra-Rg在说明书中定义），以及一种修复和保护中枢或周围神经变性的方法，包括使用式(1)代表的芴酮衍生物（其中R1、R2、p和q在说明书中定义）作为活性成分。